StonvexLoading…
StonvexStonvexStonvexCore line items from MYE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $825.74M | $836.28M | $813.07M | $899.55M |
Operating Income | $74.56M | $44.48M | $72.41M | $83.94M |
Net Income | $34.93M | $7.20M | $48.87M | $60.27M |
EPS (Diluted) | $0.93 | $0.19 | $1.32 | $1.64 |
Total Assets | $851.32M | $860.82M | $541.63M | $542.63M |
Total Liabilities | $557.10M | $583.30M | $248.83M | $286.21M |
Cash & Equivalents | $45.05M | $32.22M | $30.29M | $23.14M |
Free Cash Flow OCF − CapEx | $67.21M | $54.86M | $63.32M | $48.33M |
Shares Outstanding | 37.38M | 37.26M | 36.85M | 36.50M |